Cargando…

Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19

Clinical studies have identified a cytokine storm in the third stage of disease progression in critical ill patients with coronavirus disease 2019 (COVID-19). Hence, effectively suppressing the uncontrolled immune response of the host towards the invaded viruses in a cytokine storm is a critical ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Shikha, Saxena, Bhagawati, Mehta, Priti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846241/ https://www.ncbi.nlm.nih.gov/pubmed/33553708 http://dx.doi.org/10.1016/j.heliyon.2021.e06158

Ejemplares similares

Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
por: Douedi, Steven, et al.
Publicado: (2020)

Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
por: Zhao, Ming
Publicado: (2020)

VISTA: A Target to Manage the Innate Cytokine Storm
por: ElTanbouly, Mohamed A., et al.
Publicado: (2021)

Review on therapeutic targets for COVID-19: insights from cytokine storm
por: de Mélo Silva Júnior, Mário Luciano, et al.
Publicado: (2020)

Recent progress in the molecular imaging of therapeutic monoclonal antibodies
por: He, Kaifeng, et al.
Publicado: (2020)

Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
por: Pum, Alexandra, et al.
Publicado: (2021)

COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)

Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis
por: Kharga, Kusum, et al.
Publicado: (2023)

Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases
por: Johnson, Aishwarya Mary, et al.
Publicado: (2021)

An update to monoclonal antibody as therapeutic option against COVID-19
por: Deb, Paroma, et al.
Publicado: (2021)

Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020)

A Neonate With Cytokine Storm Managed With Steroids, Therapeutic Plasma Exchange, and Tocilizumab
por: LiKamWa, Amy, et al.
Publicado: (2023)

Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm?
por: Mornese Pinna, Simone, et al.
Publicado: (2021)

Monoclonal antibodies for migraine: an update
por: Castle, Daniel, et al.
Publicado: (2018)

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
por: Peter, Angela E., et al.
Publicado: (2021)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
por: Gravbrot, Nicholas, et al.
Publicado: (2019)

Targeting inflammation and cytokine storm in COVID-19
por: Huang, Qianwen, et al.
Publicado: (2020)

A research update: Significance of cytokine storm and diaphragm in COVID-19
por: Mittal, Ashwani, et al.
Publicado: (2021)

Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations
por: Mehta, Yatin, et al.
Publicado: (2020)

Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm
por: Morgulchik, Nelli, et al.
Publicado: (2021)

Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome
por: Beraud, Mickael, et al.
Publicado: (2022)

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
por: Chavda, Vivek P., et al.
Publicado: (2023)

Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review
por: Roshanravan, Neda, et al.
Publicado: (2020)

Anti-CD28 Antibody-Initiated Cytokine Storm in Canines
por: Rosinski, Steven L., et al.
Publicado: (2015)

Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
por: Khan, Mohsin Ali, et al.
Publicado: (2021)

Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
por: Bhaskar, Sonu, et al.
Publicado: (2020)

The looming storm: Blood and cytokines in COVID-19
por: Kaur, Supreet, et al.
Publicado: (2021)

COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
por: Nile, Shivraj Hariram, et al.
Publicado: (2020)

Emerging aspects of cytokine storm in COVID-19: the role of proinflammatory cytokines and therapeutic prospects
por: Dharra, Renu, et al.
Publicado: (2023)

Monoclonal Antibodies Targeting Ion Channels and Their Therapeutic Potential
por: Haustrate, Aurélien, et al.
Publicado: (2019)

Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm
por: Abusalah, Mai Abdel Haleem, et al.
Publicado: (2022)

Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
por: Rabiu Abubakar, Abdullahi, et al.
Publicado: (2022)

Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review
por: Quirch, Miguel, et al.
Publicado: (2020)

Point‐of‐care detection of cytokines in cytokine storm management and beyond: Significance and challenges
por: Liu, Guozhen, et al.
Publicado: (2021)

Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020)

Therapeutic effects of eugenol in a rat model of traumatic brain injury: A behavioral, biochemical, and histological study
por: Barot, Jeetprakash, et al.
Publicado: (2021)

Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies
por: Kaffash Farkhad, Najmeh, et al.
Publicado: (2021)

COVID-19: consider cytokine storm syndromes and immunosuppression
por: Mehta, Puja, et al.
Publicado: (2020)

Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review
por: Dey, Amit, et al.
Publicado: (2023)

The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm
por: Zhu, Sipin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2n9o8icbq9r8hk3knqjapa8to9